- About AAAP
- Member Center
- Meetings and Events
- Education and Training
- Buprenorphine
Policy Statements
Statements by the American Academy of Addiction Psychiatry are not intended to serve as a standard of
medical care or treatment, nor do they necessarily reflect the views of individual AAAP members. These
statements are not intended for use in making judgments about appropriate methods of care, treatment, or
procedures, medical malpractice, disability determination, competency, or any other medical or legal
matters.
- Use of Opioids in the Treatment of Chronic, Non-Malignant Pain (revised January 2009)
- Treating Tobacco Use Practice Guideline 2008, Center for Research and Tobacco Intervention (2008)
- Ability of Physicians to Practice Medicine with a Diagnosis of an Illness and/or Restricted License (revised 2008)
- Co-Occurring Psychiatric and Substance Use Disorder Treatment (December 2002)
- Criminal Justice System and Substance Use Disorder Treatment Policy (December 2002)
- Confidentiality (October 2002)
- Treatment Parity (October 2002)
- Clean Needle and Syringe (July 2002)
- Medical Use of Marijuana (June 2002)
- Organ Transplantation (November 2001)
- Use of Illegal Substances by Pregnant Women (November 2001)
- Office Based Opioid Treatment (May 1999)
- Relationship Between Treatment and Self Help (December 1997)
- Nicotine Dependence (October 1995)
- Addressing Substance Abuse: A Priority in Health Care Reform (December 1993)
- National Minimal Benefits Health Care Package (May 1993)
- Legalization of Drugs (September 1990)